Percutaneous transcatheter therapy of non-coronary structural cardiac disease

Hellenic Journal of Cardiology

Volumn 54, Issue 6, 2013, Pages 455-463

  Vavuranakis, Manolis ^a   Aznaouridis, Konstantinos ^a   Stefanadis, Christodoulos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Aortic stenosis; Atrial septal defect; Paravalvular leak; Transcatheter aortic valve implantation

Indexed keywords

AORTA VALVE STENOSIS; AORTIC VALVE REPAIR; CALCIFICATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ECHOGRAPHY; FLUOROSCOPY; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; PARAVALVULAR LEAK; POSTOPERATIVE COMPLICATION; PROSTHETIC VALVE ENDOCARDITIS; QUALITY OF LIFE; REVIEW; THORACOTOMY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSLUMINAL VALVULOPLASTY; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

CARDIAC CATHETERIZATION; HEART DISEASES; HUMANS; TREATMENT OUTCOME;

EID: 84889673034     PISSN: 11099666     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Cubeddu RJ, Inglessis I, Palacios IF. Structural heart disease interventions: an emerging discipline in cardiovascular medicine. J Invasive Cardiol. 2009; 21: 478-482.
2. Contaldi C, Losi MA, Rapacciuolo A, et al. Percutaneous treatment of patients with heart diseases: selection, guidance and follow-up. A review. Cardiovasc Ultrasound. 2012; 10: 16.
3. Parcharidis G. Interventional cardiology for structural heart disease. Hellenic J Cardiol. 2012; 53: 403-404.
4. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 24: 1231-1243.
5. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012; 33: 2451-2496.
6. Vavuranakis M, Voudris V, Vrachatis DA, et al. Transcath-eter aortic valve implantation, patient selection process and procedure: two centres' experience of the intervention without general anaesthesia. Hellenic J Cardiol. 2010; 51: 492-500.
7. Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/ SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012; 59: 1200-1254.
8. Spargias K, Manginas A, Pavlides G, et al. Transcatheter aortic valve implantation: first Greek experience. Hellenic J Car-diol. 2008; 49: 397-407.
9. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364: 2187-2198.
10. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363: 1597-1607.
11. Di Mario C, Eltchaninoff H, Moat N, et al. The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients. EuroInter-vention. 2013; 8: 1362-1371.
12. Patsalis PC, Konorza TF, Al-Rashid F, et al. Incidence, outcome and correlates of residual paravalvular aortic regurgita-tion after transcatheter aortic valve implantation and importance of haemodynamic assessment. EuroIntervention. 2013; 8: 1398-1406.
13. Vavuranakis M, Vrachatis D, Stefanadis C. CoreValve aortic bioprosthesis: repositioning techniques. JACC Cardiovasc In-terv. 2010; 3: 565.
14. Vavuranakis M, Kariori M, Vrachatis D, et al. "Balloon with-drawal technique" to correct prosthesis malposition and treat paravalvular aortic regurgitation during TAVI. J Invasive Cardiol. 2013; 25: 196-197.
15. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 24: 1231-1243.
16. Barbieri A, Bursi F, Grigioni F, et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a mul-ticenter long-term international study. Eur Heart J. 2011; 32: 751-759.
17. Tribouilloy C, Grigioni F, Avierinos JF, et al. Survival implication of left ventricular end-systolic diameter in mitral re-gurgitation due to flail leaflets a long-term follow-up multi-center study. J Am Coll Cardiol. 2009; 54: 1961-1968.
18. Salvador L, Mirone S, Bianchini R, et al. A 20-year experience with mitral valve repair with artificial chordae in 608 patients. J Thorac Cardiovasc Surg. 2008; 135: 1280-1287.
19. Schofer J, Siminiak T, Haude M, et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation. 2009; 120: 326-333.
20. Alegria-Barrero E, Chan PH, Paulo M, et al. Edge-to-edge percutaneous repair of severe mitral regurgitation-state-of-the-art for Mitraclip® implantation. Circ J. 2012; 76: 801-808.
21. Chiam PT, Ruiz CE. Percutaneous transcatheter mitral valve repair: a classification of the technology. JACC Cardiovasc Interv. 2011; 4: 1-13.
22. Spargias K, Chrissoheris M, Halapas A, et al. Percutaneous mitral valve repair using the edge-to-edge technique: first Greek experience. Hellenic J Cardiol. 2012; 53: 343-351.
23. Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011; 364: 1395-1406.
24. Mauri L, Foster E, Glower DD, et al. 4-year results of a randomized controlled trial of percutaneous repair versus sur-gery for mitral regurgitation. J Am Coll Cardiol. 2013; 62: 317-328.
25. Maisano F, Franzen O, Baldus S, et al. MitraClip therapy demonstrates favourable mid-term outcomes in ACCESS-EUROPE heart failure patients with left ventricular ejection fraction 30%: Preliminary report from the 6-month AC-CESS-EU analysis cohort. EuroIntervention 2011; 7 (Suppl M).
26. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010; 31: 2915-2957.
27. Aggeli C, Bellamy M, Sutaria N, Stefanadis C, Nihoyan-nopoulos P. Real-time 3-dimensional transoesophageal echo-cardiography: an indispensable resident in the catheter laboratory. Hellenic J Cardiol. 2012; 53: 1-5.
28. Johri AM, Witzke C, Solis J, et al. Real-time three-dimensional transesophageal echocardiography in patients with se-cundum atrial septal defects: outcomes following transcathe-ter closure. J Am Soc Echocardiogr. 2011; 24: 431-437.
29. Humenberger M, Rosenhek R, Gabriel H, et al. Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J. 2011; 32: 553-560.
30. Diab K, Kenny D, Hijazi ZM. Erosions, erosions, and erosions! Device closure of atrial septal defects: how safe is safe? Catheter Cardiovasc Interv. 2012; 80: 168-174.
31. Messé SR, Kent DM. Still no closure on the question of PFO closure. N Engl J Med. 2013; 368: 1152-1153.
32. Kim MS, Casserly IP, Garcia JA, Klein AJ, Salcedo EE, Carroll JD. Percutaneous transcatheter closure of prosthetic mitral paravalvular leaks: are we there yet? JACC Cardiovasc Interv. 2009; 2: 81-90.
33. Pate GE, Al Zubaidi A, Chandavimol M, Thompson CR, Munt BI, Webb JG. Percutaneous closure of prosthetic para-valvular leaks: case series and review. Catheter Cardiovasc Interv. 2006; 68: 528-533.
34. Rihal CS, Sorajja P, Booker JD, Hagler DJ, Cabalka AK. Principles of percutaneous paravalvular leak closure. JACC Cardiovasc Interv. 2012; 5: 121-130.